These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 19929844)

  • 1. Experimental and clinical studies on Rifacinna--the new effective antituberculous drug (review).
    Velichka D; Ivana A; Haruaki T; Katsumasa S; Venkata R; Nadadhur G; Donna D; Todor K; Arvind D; Yurii F; Ljudmila Y; Toumanov A; Zvetana Z; Chiaki S
    Recent Pat Antiinfect Drug Discov; 2010 Jan; 5(1):76-90. PubMed ID: 19929844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimycobacterial activity of a new rifamycin derivative, 3-(4-cinnamylpiperazinyl iminomethyl) rifamycin SV (T9).
    Reddy VM; Nadadhur G; Daneluzzi D; Dimova V; Gangadharam PR
    Antimicrob Agents Chemother; 1995 Oct; 39(10):2320-4. PubMed ID: 8619589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of new rifamycins against rifampicin-resistant M. tuberculosis and MAIS-complex mycobacteria.
    Dickinson JM; Mitchison DA
    Tubercle; 1987 Sep; 68(3):177-82. PubMed ID: 2834842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and bactericidal activity of rifalazil in patients with pulmonary tuberculosis.
    Dietze R; Teixeira L; Rocha LM; Palaci M; Johnson JL; Wells C; Rose L; Eisenach K; Ellner JJ
    Antimicrob Agents Chemother; 2001 Jul; 45(7):1972-6. PubMed ID: 11408210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies on therapeutic efficacy of a new anti-tuberculous drug, benzoxazinorifamycin, against murine experimental mycobacterial infections: attempt at various regimens and protocols].
    Tomioka H; Saito H
    Kekkaku; 1994 Nov; 69(11):703-10. PubMed ID: 7837724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prospects for development of new antituberculous drugs].
    Tomioka H
    Kekkaku; 2002 Aug; 77(8):573-84. PubMed ID: 12235850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rifabutin (ansamycin LM 427): a new rifamycin-S derivative for the treatment of mycobacterial diseases.
    O'Brien RJ; Lyle MA; Snider DE
    Rev Infect Dis; 1987; 9(3):519-30. PubMed ID: 3037676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative in vitro and in vivo activity of rifabutin and rifampicin against Mycobacterium avium complex.
    Saito H; Sato K; Tomioka H
    Tubercle; 1988 Sep; 69(3):187-92. PubMed ID: 2855458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity in vitro of rifabutin, FCE 22807, rifapentine, and rifampin against Mycobacterium microti and M. tuberculosis and their penetration into mouse peritoneal macrophages.
    Dhillon J; Mitchison DA
    Am Rev Respir Dis; 1992 Jan; 145(1):212-4. PubMed ID: 1309967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between antimycobacterial activities of rifampicin, rifabutin and KRM-1648 and rpoB mutations of Mycobacterium tuberculosis.
    Yang B; Koga H; Ohno H; Ogawa K; Fukuda M; Hirakata Y; Maesaki S; Tomono K; Tashiro T; Kohno S
    J Antimicrob Chemother; 1998 Nov; 42(5):621-8. PubMed ID: 9848446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rifamycin inhibition of WT and Rif-resistant Mycobacterium tuberculosis and Escherichia coli RNA polymerases in vitro.
    Gill SK; Garcia GA
    Tuberculosis (Edinb); 2011 Sep; 91(5):361-9. PubMed ID: 21704562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose aerosol infection model for testing drugs for efficacy against Mycobacterium tuberculosis.
    Kelly BP; Furney SK; Jessen MT; Orme IM
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2809-12. PubMed ID: 9124846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial activities of cinnamyl rifamycin derivatives, T-9 and T-11, against Mycobacterium tuberculosis and Mycobacterium avium complex (MAC) with special reference to the activities against intracellular MAC.
    Sato K; Shimizu T; Dimova V; Tomioka H
    Microbiol Immunol; 2006; 50(8):621-3. PubMed ID: 16924146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospects for development of new antimycobacterial drugs, with special reference to a new benzoxazinorifamycin, KRM-1648.
    Tomioka H
    Arch Immunol Ther Exp (Warsz); 2000; 48(3):183-8. PubMed ID: 10912623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic efficacy of benzoxazinorifamycin KRM-1648 against experimental murine tuberculosis: (1). A study on the efficacy of short course treatment with the intratracheal and intravenous infection model].
    Doi N
    Kekkaku; 1998 Feb; 73(2):53-64. PubMed ID: 9545697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study of the minimal inhibitory concentration of rifabutine (Ansamycin LM 427) for Mycobacterium tuberculosis, Mycobacterium xenopi and Mycobacterium avium-intracellulare].
    Truffot-Pernot C; Giroir AM; Maury L; Grosset J
    Rev Mal Respir; 1988; 5(4):401-6. PubMed ID: 2845531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of rifapentine and its metabolite 25-O-desacetylrifapentine compared with rifampicin and rifabutin against Mycobacterium tuberculosis, Mycobacterium africanum, Mycobacterium bovis and M. bovis BCG.
    Rastogi N; Goh KS; Berchel M; Bryskier A
    J Antimicrob Chemother; 2000 Oct; 46(4):565-70. PubMed ID: 11020253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospects for development of new antimycobacterial drugs.
    Tomioka H
    J Infect Chemother; 2000 Mar; 6(1):8-20. PubMed ID: 11810525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapeutic activity of benzoxazinorifamycin, KRM-1648, against Mycobacterium tuberculosis in C57BL/6 mice.
    Reddy MV; Luna-Herrera J; Daneluzzi D; Gangadharam PR
    Tuber Lung Dis; 1996 Apr; 77(2):154-9. PubMed ID: 8762850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.